Ashigarakami, Japan

Kohei Ono

This inventor holds 6 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignee: Fujifilm Corporation. Active years: 2018-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kohei Ono. Retrieved from https://idiyas.com/inventor/kohei-ono-3205l40z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0


Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 12(Granted Patents)


Location History:

  • Kanagawa, JP (2020)
  • Ashigarakami-gun, JP (2018 - 2023)

Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Kohei Ono: A Pioneer in Liposome Technology

Introduction

Kohei Ono, an esteemed inventor hailing from Ashigarakami-gun, Japan, has made significant contributions to the field of drug delivery systems. With a total of six patents to his name, Ono has focused on innovative solutions that enhance the stability and efficacy of liposome compositions for pharmaceutical applications.

Latest Patents

Ono's most recent invention revolves around a novel liposome composition and method for its production. This invention addresses the need for long-term stability in liposome formulations, achieving a controlled release rate for drugs over extended periods. Specifically, the liposome composition consists of liposomes that contain an inner hyper-osmotic water phase and an outer aqueous solution, where cholesterols are present in the range of 10 mol % to 35 mol % of the total lipid components. Each liposome encapsulates a drug in a dissolved state, enhancing its therapeutic potential.

Career Highlights

Throughout his career, Kohei Ono has worked with Fujifilm Corporation, where he has leveraged his expertise in innovative drug delivery technologies. His commitment to research and development has led to groundbreaking advancements in liposome formulations, which are critical for improving drug bioavailability and patient outcomes.

Collaborations

Ono has collaborated with esteemed colleagues, including Makoto Ono and Takeshi Matsumoto. These partnerships have fostered a dynamic environment for innovation, enabling them to share insights and drive forward the development of effective pharmaceutical formulations.

Conclusion

In conclusion, Kohei Ono stands out as a notable inventor whose work in liposome technology has the potential to revolutionize drug delivery methods. With his latest patents paving the way for improved drug stability and release, Ono is set to make a lasting impact in the pharmaceutical industry. His dedication to innovation, backed by fruitful collaborations, will undoubtedly continue to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…